Does Tofacitinib improve disease signs and symptoms and maintain safety in Canadian patients with Rheumatoid Arthritis?
Canadian patients with Rheumatoid Arthritis
Tofacitinib
disease signs and symptoms and safetysafety
Tofacitinib demonstrated sustained effectiveness and a consistent safety profile over 36 months in Canadian patients with rheumatoid arthritis.
Tofacitinib provided early and sustained improvement of disease signs and symptoms in patients with RA in Canada. Safety was consistent with the RA clinical program and the established tofacitinib clinical profile. Results were consistent with the interim analysis.
Building similarity graph...
Analyzing shared references across papers
Loading...
Boulos Haraoui
D. Choquette
Cristina D. Sciortino
Rheumatology and Therapy
McGill University
Pfizer (United States)
Memorial University of Newfoundland
Building similarity graph...
Analyzing shared references across papers
Loading...
Haraoui et al. (Mon,) studied this question.
www.synapsesocial.com/papers/69df2b49e4eeef8a2a6b0417 — DOI: https://doi.org/10.1007/s40744-026-00854-1